Evidence Level
Turmeric / Curcumin is one of the most extensively studied natural compounds, with over 17,000 published papers in PubMed. The clinical evidence for its efficacy is robust across multiple health domains.
For joint health, Daily et al. (2016) conducted a systematic review and meta-analysis of eight randomized controlled trials (RCTs), involving 459 participants, demonstrating that curcumin (~1000 mg/day) significantly reduced arthritis symptoms compared to placebo, with comparable efficacy to ibuprofen but superior gastrointestinal safety.
In terms of bioavailability, Shoba et al. (1998) found that co-administration of piperine with curcumin increased its absorption by 2000%. Additionally, Cuomo et al. (2011) reported that Meriva phytosome achieved a 29-fold higher plasma concentration of curcumin compared to unformulated extracts.
In neurological research, Small et al. (2018) published a rigorous 18-month RCT in the American Journal of Geriatric Psychiatry, showing that Theracurmin improved memory, attention, and mood in non-demented adults while reducing amyloid and tau deposition on brain PET scans—a significant advancement in supplement research.
Recent studies have also highlighted curcumin's benefits for metabolic health. Moradi Baniasadi et al. (2025) conducted a systematic review and meta-analysis of 20 RCTs involving 1,057 participants, finding that turmeric/curcumin supplementation significantly reduced body weight (-1.9 kg), waist circumference (-1.9 cm), fat mass% (-2.9%), and hip circumference (-1.0 cm) in individuals with prediabetes and type 2 diabetes mellitus.
Kehinde et al. (2025) reviewed 104 RCTs involving 5,392 adults, concluding that Curcuma longa supplementation significantly improved glycemic regulation, lipid metabolism, and inflammatory-oxidative balance in individuals with metabolic syndrome or related conditions.
Goodarzi et al. (2019) found that turmeric/curcumin supplementation significantly reduced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in patients with nonalcoholic fatty liver disease, while White et al. (2019) demonstrated its anti-inflammatory effects in chronic inflammatory diseases.
Overall